Grants and Contributions:
Title:
Bench and Preclinical Study, Prototyping, Regulatory Study Design, and Pilots
Agreement Number:
1034494
Agreement Value:
$225,000.00
Agreement Date:
Aug 1, 2025 - Jun 30, 2026
Description:
PulseMedica is advancing its floater treatment system (SVO-Tx), a 3D image-guided femtosecond laser device for the non-invasive treatment of symptomatic vitreous opacities (SVOs or eye floaters). This project will complete preclinical laser safety validation, system performance verification, and assembly finalization, along with certification of two clinic-ready prototypes. It will also support development of clinical protocols and regulatory documentation in preparation for a First-in-Human (FIH) study, to follow beyond this project’s scope.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T5N 3M3
Reference Number:
172-2025-2026-Q2-1034494
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
776889289
Recipient Type:
For-profit organization
Recipient's Operating Name:
PulseMedica
Recipient's Legal Name:
PulseMedica Corp.
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512